{"id":5320,"date":"2024-05-17T11:16:00","date_gmt":"2024-05-17T08:16:00","guid":{"rendered":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2026\/01\/19\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/"},"modified":"2026-01-19T11:11:58","modified_gmt":"2026-01-19T08:11:58","slug":"09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk","status":"publish","type":"post","link":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/","title":{"rendered":"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK."},"content":{"rendered":"<div style=\"padding-bottom: 100px; margin: auto; width: 90%; display: flex; justify-content: center; flex-direction: column;\">\n<p style=\"text-align: center; \"><b>09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ ve KAR\u015eILA\u015eTIRMALI TABLO EKTE YAYINLANMI\u015eTIR<\/b><\/p>\n<p><\/p>\n<h4>1. \u0130lk defa tedavi alan hastalar i\u00e7in 28 tabletlik ila\u00e7 formlar\u0131n\u0131n art\u0131k 2 kutu \u00f6denmesi durumu kald\u0131r\u0131lm\u0131\u015ft\u0131r.&nbsp;<br \/>2. \u2060RINVOQ (upadesitinib) i\u00e7in Crohn ve \u00fclseratif kolit hastal\u0131klar\u0131nda geri \u00f6deme al\u0131nm\u0131\u015ft\u0131r<br \/>3. \u2060\u0130laris ( kanakinumab) i\u00e7in SJIA tan\u0131s\u0131nda endikasyon d\u0131\u015f\u0131 form \u015fart\u0131 kald\u0131r\u0131ld\u0131.&nbsp;<br \/>4. \u2060\u0130laris ( kanakinumab) i\u00e7in tedaviye SUT h\u00fck\u00fcmlerinin y\u00fcr\u00fcrl\u00fcl\u00fck tarihinden \u00f6nce ba\u015flayan hastalar i\u00e7in tedavi DEVAM \u015fartlar\u0131n\u0131n sa\u011flanmas\u0131 halinde ba\u015flang\u0131\u00e7 ko\u015fullar\u0131 aranmayacakt\u0131r.&nbsp;<br \/>5. \u2060B\u00fcy\u00fcme hormonu bozukluklar\u0131nda SUT\u2019ta aranan \u201cbeslenme bozuklu\u011fu \u201c ibaresi kald\u0131r\u0131lm\u0131\u015ft\u0131r. B\u00f6ylece enteral beslenme \u00fcr\u00fcnleri ile beraber b\u00fcy\u00fcme hormonlar\u0131n\u0131n e\u015f zamanl\u0131 kullan\u0131m\u0131 m\u00fcmk\u00fcn hale getirilmi\u015ftir.&nbsp;<br \/>6. \u2060B\u00fcy\u00fcme hormonu tedavisinde sonlanma kriterlerinden biri olan kemik ya\u015f\u0131 k\u0131stas\u0131 kald\u0131r\u0131ld\u0131.&nbsp;<br \/>7. \u2060Enteral beslenme \u00fcr\u00fcnlerinde ba\u015flang\u0131\u00e7 raporunu \u00e7\u0131karabilecek hekimlere \u00e7ocuk cerrahi hekimi eklenmi\u015ftir.&nbsp;<br \/>8. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in raporsuz en fazla bir kutu \u00f6denece\u011fi bildirilmi\u015ftir.&nbsp;<br \/>9. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in raporsuz da olsa endikasyon \u015fart\u0131 getirilmi\u015ftir.&nbsp;<br \/>10. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in ayn\u0131 grupta yer alan etkin maddeleri i\u00e7eren iki ayr\u0131 nebul kombine kullan\u0131lamaz \u015fart\u0131 getirilmi\u015ftir.<br \/>11. \u2060Soliqua solastar ( ins\u00fclin glarjin+liksisenatid) Tip-2 diyabetli hastalar\u0131n tedavisinde geri \u00f6demeye al\u0131nm\u0131\u015ft\u0131r.&nbsp;<br \/>12. \u2060Parenteral demir preparatlar\u0131 i\u00e7in rapor d\u00fczenleme \u015fart\u0131na ilgili hekim kurallar\u0131 getirilmi\u015ftir .&nbsp;<br \/>13. \u2060Gabapentin , pregabalin ve kombinasyonlar\u0131; alfa lipoik asit ve duloksetin geri \u00f6demeleri i\u00e7in \u00f6zel ICD tan\u0131mlamalar\u0131 yap\u0131lm\u0131\u015ft\u0131r.&nbsp;<br \/>14. \u2060Gabapentin ve pregabalin i\u00e7in rapor s\u00fcresi 3 aydan 6 aya \u00e7\u0131kar\u0131lm\u0131\u015ft\u0131r.&nbsp;<br \/>15. \u2060Colidur 200 (rifaksimin) i\u00e7in geri \u00f6demede ; akut GIS enfeksiyon, hiperamonemi tedavisinde koadjuvan olarak ve diyare bask\u0131n irritabl ba\u011f\u0131rsak sendromu tan\u0131lar\u0131 ek-4f listesinde g\u00fcncellenmi\u015ftir.&nbsp;<br \/>16. \u2060Colidur 500 i\u00e7in 18 ya\u015f ve \u00fczerindeki hastalarda a\u015fikar(overt) hepatit ensefalopati&nbsp; epizodlar\u0131n\u0131n azalt\u0131lmas\u0131 tan\u0131s\u0131 \u015fart\u0131 getirilmi\u015ftir&nbsp;<br \/>17. \u2060Ziver ( ivermektin) uyuz , intestinal strongilodiyaz, lenfatik filariasisi , mikrofilaremi tan\u0131lar\u0131nda \u00f6zel ko\u015fullarla beraber geri \u00f6demeye al\u0131nm\u0131\u015ft\u0131r.&nbsp;<br \/>18. \u2060Granitron, ondansetron, tropisetron 21 g\u00fcnl\u00fck k\u00fcr tedavisinde en fazla 10 g\u00fcnl\u00fck \u00f6denecektir.&nbsp;<br \/>19. \u2060Palonosetron Hcl ( palonex ) her bir k\u00fcrde 7 g\u00fcn i\u00e7in 1 flakon olacak \u015fekilde \u00f6denecektir.<br \/>20. \u2060Emend ( aprepitant) bir k\u00fcr s\u00fcresince en fazla 1 kutu \u00f6denecektir .<\/h4>\n<p><\/p>\n<ul>\n<li><a href=\"https:\/\/sanliurfaeo.birodam.org.tr\/images\/1715344788.pdf\"><b><font color=\"#0000ff\">sut-karsilastirmali-tablo.pdf<\/font><\/b><\/a><\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ ve KAR\u015eILA\u015eTIRMALI TABLO EKTE YAYINLANMI\u015eTIR 1. \u0130lk defa tedavi alan hastalar i\u00e7in 28 tabletlik ila\u00e7 formlar\u0131n\u0131n art\u0131k 2 kutu \u00f6denmesi durumu kald\u0131r\u0131lm\u0131\u015ft\u0131r.&nbsp;2. \u2060RINVOQ (upadesitinib) i\u00e7in Crohn ve \u00fclseratif kolit hastal\u0131klar\u0131nda geri \u00f6deme al\u0131nm\u0131\u015ft\u0131r3. \u2060\u0130laris ( kanakinumab) i\u00e7in SJIA tan\u0131s\u0131nda endikasyon d\u0131\u015f\u0131 form \u015fart\u0131 kald\u0131r\u0131ld\u0131.&nbsp;4. \u2060\u0130laris ( kanakinumab) i\u00e7in tedaviye SUT h\u00fck\u00fcmlerinin y\u00fcr\u00fcrl\u00fcl\u00fck tarihinden \u00f6nce ba\u015flayan hastalar i\u00e7in tedavi DEVAM \u015fartlar\u0131n\u0131n sa\u011flanmas\u0131 halinde ba\u015flang\u0131\u00e7 ko\u015fullar\u0131 aranmayacakt\u0131r.&nbsp;5. \u2060B\u00fcy\u00fcme hormonu bozukluklar\u0131nda SUT\u2019ta aranan \u201cbeslenme bozuklu\u011fu \u201c ibaresi kald\u0131r\u0131lm\u0131\u015ft\u0131r. B\u00f6ylece enteral beslenme \u00fcr\u00fcnleri ile beraber b\u00fcy\u00fcme hormonlar\u0131n\u0131n e\u015f zamanl\u0131 kullan\u0131m\u0131 m\u00fcmk\u00fcn hale getirilmi\u015ftir.&nbsp;6. \u2060B\u00fcy\u00fcme hormonu tedavisinde sonlanma kriterlerinden biri olan kemik ya\u015f\u0131 k\u0131stas\u0131 kald\u0131r\u0131ld\u0131.&nbsp;7. \u2060Enteral beslenme \u00fcr\u00fcnlerinde ba\u015flang\u0131\u00e7 raporunu \u00e7\u0131karabilecek hekimlere \u00e7ocuk cerrahi hekimi eklenmi\u015ftir.&nbsp;8. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in raporsuz en fazla bir kutu \u00f6denece\u011fi bildirilmi\u015ftir.&nbsp;9. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in raporsuz da olsa endikasyon \u015fart\u0131 getirilmi\u015ftir.&nbsp;10. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in ayn\u0131 grupta yer alan etkin maddeleri i\u00e7eren iki ayr\u0131 nebul kombine kullan\u0131lamaz \u015fart\u0131 getirilmi\u015ftir.11. \u2060Soliqua solastar ( ins\u00fclin glarjin+liksisenatid) Tip-2 diyabetli hastalar\u0131n tedavisinde geri \u00f6demeye al\u0131nm\u0131\u015ft\u0131r.&nbsp;12. \u2060Parenteral demir preparatlar\u0131 i\u00e7in rapor d\u00fczenleme \u015fart\u0131na ilgili hekim kurallar\u0131 getirilmi\u015ftir .&nbsp;13. \u2060Gabapentin , pregabalin ve kombinasyonlar\u0131; alfa lipoik asit ve duloksetin geri \u00f6demeleri i\u00e7in \u00f6zel ICD tan\u0131mlamalar\u0131 yap\u0131lm\u0131\u015ft\u0131r.&nbsp;14. \u2060Gabapentin ve pregabalin i\u00e7in rapor s\u00fcresi 3 aydan 6 aya \u00e7\u0131kar\u0131lm\u0131\u015ft\u0131r.&nbsp;15. \u2060Colidur 200 (rifaksimin) i\u00e7in geri \u00f6demede ; akut GIS enfeksiyon, hiperamonemi tedavisinde koadjuvan olarak ve diyare bask\u0131n irritabl ba\u011f\u0131rsak sendromu tan\u0131lar\u0131 ek-4f listesinde g\u00fcncellenmi\u015ftir.&nbsp;16. \u2060Colidur 500 i\u00e7in 18 ya\u015f ve \u00fczerindeki hastalarda a\u015fikar(overt) hepatit ensefalopati&nbsp; epizodlar\u0131n\u0131n azalt\u0131lmas\u0131 tan\u0131s\u0131 \u015fart\u0131 getirilmi\u015ftir&nbsp;17. \u2060Ziver ( ivermektin) uyuz , intestinal strongilodiyaz, lenfatik filariasisi , mikrofilaremi tan\u0131lar\u0131nda \u00f6zel ko\u015fullarla beraber geri \u00f6demeye al\u0131nm\u0131\u015ft\u0131r.&nbsp;18. \u2060Granitron, ondansetron, tropisetron 21 g\u00fcnl\u00fck k\u00fcr tedavisinde en fazla 10 g\u00fcnl\u00fck \u00f6denecektir.&nbsp;19. \u2060Palonosetron Hcl ( palonex ) her bir k\u00fcrde 7 g\u00fcn i\u00e7in 1 flakon olacak \u015fekilde \u00f6denecektir.20. \u2060Emend ( aprepitant) bir k\u00fcr s\u00fcresince en fazla 1 kutu \u00f6denecektir . sut-karsilastirmali-tablo.pdf<\/p>\n","protected":false},"author":4,"featured_media":191,"comment_status":"open","ping_status":"open","sticky":false,"template":"elementor_canvas","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5320","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oda"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"og:description\" content=\"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ ve KAR\u015eILA\u015eTIRMALI TABLO EKTE YAYINLANMI\u015eTIR 1. \u0130lk defa tedavi alan hastalar i\u00e7in 28 tabletlik ila\u00e7 formlar\u0131n\u0131n art\u0131k 2 kutu \u00f6denmesi durumu kald\u0131r\u0131lm\u0131\u015ft\u0131r.&nbsp;2. \u2060RINVOQ (upadesitinib) i\u00e7in Crohn ve \u00fclseratif kolit hastal\u0131klar\u0131nda geri \u00f6deme al\u0131nm\u0131\u015ft\u0131r3. \u2060\u0130laris ( kanakinumab) i\u00e7in SJIA tan\u0131s\u0131nda endikasyon d\u0131\u015f\u0131 form \u015fart\u0131 kald\u0131r\u0131ld\u0131.&nbsp;4. \u2060\u0130laris ( kanakinumab) i\u00e7in tedaviye SUT h\u00fck\u00fcmlerinin y\u00fcr\u00fcrl\u00fcl\u00fck tarihinden \u00f6nce ba\u015flayan hastalar i\u00e7in tedavi DEVAM \u015fartlar\u0131n\u0131n sa\u011flanmas\u0131 halinde ba\u015flang\u0131\u00e7 ko\u015fullar\u0131 aranmayacakt\u0131r.&nbsp;5. \u2060B\u00fcy\u00fcme hormonu bozukluklar\u0131nda SUT\u2019ta aranan \u201cbeslenme bozuklu\u011fu \u201c ibaresi kald\u0131r\u0131lm\u0131\u015ft\u0131r. B\u00f6ylece enteral beslenme \u00fcr\u00fcnleri ile beraber b\u00fcy\u00fcme hormonlar\u0131n\u0131n e\u015f zamanl\u0131 kullan\u0131m\u0131 m\u00fcmk\u00fcn hale getirilmi\u015ftir.&nbsp;6. \u2060B\u00fcy\u00fcme hormonu tedavisinde sonlanma kriterlerinden biri olan kemik ya\u015f\u0131 k\u0131stas\u0131 kald\u0131r\u0131ld\u0131.&nbsp;7. \u2060Enteral beslenme \u00fcr\u00fcnlerinde ba\u015flang\u0131\u00e7 raporunu \u00e7\u0131karabilecek hekimlere \u00e7ocuk cerrahi hekimi eklenmi\u015ftir.&nbsp;8. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in raporsuz en fazla bir kutu \u00f6denece\u011fi bildirilmi\u015ftir.&nbsp;9. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in raporsuz da olsa endikasyon \u015fart\u0131 getirilmi\u015ftir.&nbsp;10. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in ayn\u0131 grupta yer alan etkin maddeleri i\u00e7eren iki ayr\u0131 nebul kombine kullan\u0131lamaz \u015fart\u0131 getirilmi\u015ftir.11. \u2060Soliqua solastar ( ins\u00fclin glarjin+liksisenatid) Tip-2 diyabetli hastalar\u0131n tedavisinde geri \u00f6demeye al\u0131nm\u0131\u015ft\u0131r.&nbsp;12. \u2060Parenteral demir preparatlar\u0131 i\u00e7in rapor d\u00fczenleme \u015fart\u0131na ilgili hekim kurallar\u0131 getirilmi\u015ftir .&nbsp;13. \u2060Gabapentin , pregabalin ve kombinasyonlar\u0131; alfa lipoik asit ve duloksetin geri \u00f6demeleri i\u00e7in \u00f6zel ICD tan\u0131mlamalar\u0131 yap\u0131lm\u0131\u015ft\u0131r.&nbsp;14. \u2060Gabapentin ve pregabalin i\u00e7in rapor s\u00fcresi 3 aydan 6 aya \u00e7\u0131kar\u0131lm\u0131\u015ft\u0131r.&nbsp;15. \u2060Colidur 200 (rifaksimin) i\u00e7in geri \u00f6demede ; akut GIS enfeksiyon, hiperamonemi tedavisinde koadjuvan olarak ve diyare bask\u0131n irritabl ba\u011f\u0131rsak sendromu tan\u0131lar\u0131 ek-4f listesinde g\u00fcncellenmi\u015ftir.&nbsp;16. \u2060Colidur 500 i\u00e7in 18 ya\u015f ve \u00fczerindeki hastalarda a\u015fikar(overt) hepatit ensefalopati&nbsp; epizodlar\u0131n\u0131n azalt\u0131lmas\u0131 tan\u0131s\u0131 \u015fart\u0131 getirilmi\u015ftir&nbsp;17. \u2060Ziver ( ivermektin) uyuz , intestinal strongilodiyaz, lenfatik filariasisi , mikrofilaremi tan\u0131lar\u0131nda \u00f6zel ko\u015fullarla beraber geri \u00f6demeye al\u0131nm\u0131\u015ft\u0131r.&nbsp;18. \u2060Granitron, ondansetron, tropisetron 21 g\u00fcnl\u00fck k\u00fcr tedavisinde en fazla 10 g\u00fcnl\u00fck \u00f6denecektir.&nbsp;19. \u2060Palonosetron Hcl ( palonex ) her bir k\u00fcrde 7 g\u00fcn i\u00e7in 1 flakon olacak \u015fekilde \u00f6denecektir.20. \u2060Emend ( aprepitant) bir k\u00fcr s\u00fcresince en fazla 1 kutu \u00f6denecektir . sut-karsilastirmali-tablo.pdf\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/\" \/>\n<meta property=\"og:site_name\" content=\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-17T08:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-19T08:11:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Yeni Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Yeni Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/\"},\"author\":{\"name\":\"Yeni Admin\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\"},\"headline\":\"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK.\",\"datePublished\":\"2024-05-17T08:16:00+00:00\",\"dateModified\":\"2026-01-19T08:11:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/\"},\"wordCount\":450,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"articleSection\":[\"ODA\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/\",\"name\":\"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"datePublished\":\"2024-05-17T08:16:00+00:00\",\"dateModified\":\"2026-01-19T08:11:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"contentUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2024\\\/05\\\/17\\\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Anasayfa\",\"item\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#website\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#organization\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"contentUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"width\":635,\"height\":635,\"caption\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\"},\"image\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\",\"name\":\"Yeni Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"caption\":\"Yeni Admin\"},\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/author\\\/yeniadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/","og_locale":"tr_TR","og_type":"article","og_title":"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","og_description":"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ ve KAR\u015eILA\u015eTIRMALI TABLO EKTE YAYINLANMI\u015eTIR 1. \u0130lk defa tedavi alan hastalar i\u00e7in 28 tabletlik ila\u00e7 formlar\u0131n\u0131n art\u0131k 2 kutu \u00f6denmesi durumu kald\u0131r\u0131lm\u0131\u015ft\u0131r.&nbsp;2. \u2060RINVOQ (upadesitinib) i\u00e7in Crohn ve \u00fclseratif kolit hastal\u0131klar\u0131nda geri \u00f6deme al\u0131nm\u0131\u015ft\u0131r3. \u2060\u0130laris ( kanakinumab) i\u00e7in SJIA tan\u0131s\u0131nda endikasyon d\u0131\u015f\u0131 form \u015fart\u0131 kald\u0131r\u0131ld\u0131.&nbsp;4. \u2060\u0130laris ( kanakinumab) i\u00e7in tedaviye SUT h\u00fck\u00fcmlerinin y\u00fcr\u00fcrl\u00fcl\u00fck tarihinden \u00f6nce ba\u015flayan hastalar i\u00e7in tedavi DEVAM \u015fartlar\u0131n\u0131n sa\u011flanmas\u0131 halinde ba\u015flang\u0131\u00e7 ko\u015fullar\u0131 aranmayacakt\u0131r.&nbsp;5. \u2060B\u00fcy\u00fcme hormonu bozukluklar\u0131nda SUT\u2019ta aranan \u201cbeslenme bozuklu\u011fu \u201c ibaresi kald\u0131r\u0131lm\u0131\u015ft\u0131r. B\u00f6ylece enteral beslenme \u00fcr\u00fcnleri ile beraber b\u00fcy\u00fcme hormonlar\u0131n\u0131n e\u015f zamanl\u0131 kullan\u0131m\u0131 m\u00fcmk\u00fcn hale getirilmi\u015ftir.&nbsp;6. \u2060B\u00fcy\u00fcme hormonu tedavisinde sonlanma kriterlerinden biri olan kemik ya\u015f\u0131 k\u0131stas\u0131 kald\u0131r\u0131ld\u0131.&nbsp;7. \u2060Enteral beslenme \u00fcr\u00fcnlerinde ba\u015flang\u0131\u00e7 raporunu \u00e7\u0131karabilecek hekimlere \u00e7ocuk cerrahi hekimi eklenmi\u015ftir.&nbsp;8. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in raporsuz en fazla bir kutu \u00f6denece\u011fi bildirilmi\u015ftir.&nbsp;9. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in raporsuz da olsa endikasyon \u015fart\u0131 getirilmi\u015ftir.&nbsp;10. \u2060Nebul formundaki solunum sistemi ila\u00e7lar\u0131 i\u00e7in ayn\u0131 grupta yer alan etkin maddeleri i\u00e7eren iki ayr\u0131 nebul kombine kullan\u0131lamaz \u015fart\u0131 getirilmi\u015ftir.11. \u2060Soliqua solastar ( ins\u00fclin glarjin+liksisenatid) Tip-2 diyabetli hastalar\u0131n tedavisinde geri \u00f6demeye al\u0131nm\u0131\u015ft\u0131r.&nbsp;12. \u2060Parenteral demir preparatlar\u0131 i\u00e7in rapor d\u00fczenleme \u015fart\u0131na ilgili hekim kurallar\u0131 getirilmi\u015ftir .&nbsp;13. \u2060Gabapentin , pregabalin ve kombinasyonlar\u0131; alfa lipoik asit ve duloksetin geri \u00f6demeleri i\u00e7in \u00f6zel ICD tan\u0131mlamalar\u0131 yap\u0131lm\u0131\u015ft\u0131r.&nbsp;14. \u2060Gabapentin ve pregabalin i\u00e7in rapor s\u00fcresi 3 aydan 6 aya \u00e7\u0131kar\u0131lm\u0131\u015ft\u0131r.&nbsp;15. \u2060Colidur 200 (rifaksimin) i\u00e7in geri \u00f6demede ; akut GIS enfeksiyon, hiperamonemi tedavisinde koadjuvan olarak ve diyare bask\u0131n irritabl ba\u011f\u0131rsak sendromu tan\u0131lar\u0131 ek-4f listesinde g\u00fcncellenmi\u015ftir.&nbsp;16. \u2060Colidur 500 i\u00e7in 18 ya\u015f ve \u00fczerindeki hastalarda a\u015fikar(overt) hepatit ensefalopati&nbsp; epizodlar\u0131n\u0131n azalt\u0131lmas\u0131 tan\u0131s\u0131 \u015fart\u0131 getirilmi\u015ftir&nbsp;17. \u2060Ziver ( ivermektin) uyuz , intestinal strongilodiyaz, lenfatik filariasisi , mikrofilaremi tan\u0131lar\u0131nda \u00f6zel ko\u015fullarla beraber geri \u00f6demeye al\u0131nm\u0131\u015ft\u0131r.&nbsp;18. \u2060Granitron, ondansetron, tropisetron 21 g\u00fcnl\u00fck k\u00fcr tedavisinde en fazla 10 g\u00fcnl\u00fck \u00f6denecektir.&nbsp;19. \u2060Palonosetron Hcl ( palonex ) her bir k\u00fcrde 7 g\u00fcn i\u00e7in 1 flakon olacak \u015fekilde \u00f6denecektir.20. \u2060Emend ( aprepitant) bir k\u00fcr s\u00fcresince en fazla 1 kutu \u00f6denecektir . sut-karsilastirmali-tablo.pdf","og_url":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/","og_site_name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","article_published_time":"2024-05-17T08:16:00+00:00","article_modified_time":"2026-01-19T08:11:58+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","type":"image\/png"}],"author":"Yeni Admin","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Yeni Admin","Tahmini okuma s\u00fcresi":"2 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/#article","isPartOf":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/"},"author":{"name":"Yeni Admin","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120"},"headline":"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK.","datePublished":"2024-05-17T08:16:00+00:00","dateModified":"2026-01-19T08:11:58+00:00","mainEntityOfPage":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/"},"wordCount":450,"commentCount":0,"publisher":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#organization"},"image":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/#primaryimage"},"thumbnailUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","articleSection":["ODA"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/","url":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/","name":"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","isPartOf":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/#primaryimage"},"image":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/#primaryimage"},"thumbnailUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","datePublished":"2024-05-17T08:16:00+00:00","dateModified":"2026-01-19T08:11:58+00:00","breadcrumb":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/#primaryimage","url":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","contentUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2024\/05\/17\/09-05-2024-tarihli-degisen-sut-uygulamalari-ile-ilgili-ozet-calismamiz-hk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Anasayfa","item":"https:\/\/sanliurfaeo.birodam.org.tr\/"},{"@type":"ListItem","position":2,"name":"09.05.2024 TAR\u0130HLi DE\u011e\u0130\u015eEN SUT UYGULAMALARI \u0130LE \u0130LG\u0130L\u0130 \u00d6ZET \u00c7ALI\u015eMAMIZ HK."}]},{"@type":"WebSite","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#website","url":"https:\/\/sanliurfaeo.birodam.org.tr\/","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","description":"","publisher":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sanliurfaeo.birodam.org.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#organization","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","url":"https:\/\/sanliurfaeo.birodam.org.tr\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/logo\/image\/","url":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","contentUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","width":635,"height":635,"caption":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131"},"image":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120","name":"Yeni Admin","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","caption":"Yeni Admin"},"url":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/author\/yeniadmin\/"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/posts\/5320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/comments?post=5320"}],"version-history":[{"count":0,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/posts\/5320\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/media\/191"}],"wp:attachment":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/media?parent=5320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/categories?post=5320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/tags?post=5320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}